Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Milestone achieved in Millennium/Roche research collaboration

Nov. 25, 1996

Research suggests improved treatment for anemia

Nov. 25, 1996

Zonagen allowed further patent coverage for zona pellucida proteins

Nov. 25, 1996

More antiobesity proteins reported by Lilly

Nov. 25, 1996

Genentech advances NGF through the clinical development pipeline

Nov. 22, 1996

Cortecs plans oral insulin studies in diabetic patients

Nov. 22, 1996

Another French market introduction for Lescol

Nov. 22, 1996

Alkermes and Genentech expand collaboration for sustained-release human GH

Nov. 22, 1996

New impotence treatment deemed approvable by FDA

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...